Literature DB >> 8655129

A novel point mutation in congenital erythropoietic porphyria in two members of Japanese family.

K Tanigawa1, M Bensidhoum, N Takamura, H Namba, S Yamashita, H de Verneuil, C Ged.   

Abstract

The molecular basis of the uroporphyrinogen III synthase (UROIIIS) deficiency was investigated in two members of a Japanese family. This defect in heme biosynthesis is responsible for a rare autosomal recessive disease: congenital erythropoietic porphyria (CEP) or Gnther's disease. The first patient was homoallelic for a novel missense mutation: a T to C transition of nucleotide 634 that predicted a serine to proline substitution at residue 212 (S212P). The second patient appeared heteroallelic, carrying the same missense mutation and a nonsense mutation: a C to T change at nucleotide 745, resulting in a premature stop at codon 249, instead of a glutamine (Q249X). The corresponding mutated proteins were expressed in Escherichia coli and no residual activity was observed. A family study was also performed to determine the carrier status.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8655129     DOI: 10.1007/bf02281859

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  18 in total

1.  Plasmasorbent therapy with activated charcoal column for congenital erythropoietic porphyria.

Authors:  K Tanigawa; H Namba; A Ohtsuru; M Shima; K Nakata; M Kondo; S Yamashita; S Nagataki
Journal:  Dermatology       Date:  1994       Impact factor: 5.366

2.  The rapid determination of erythrocyte porphyrins using reversed-phase high performance liquid chromatography.

Authors:  H A Scoble; M McKeag; P R Brown; G J Kavarnos
Journal:  Clin Chim Acta       Date:  1981-07-01       Impact factor: 3.786

3.  Biochemical diagnosis of a fatal case of Günther's disease in a newborn with hydrops foetalis.

Authors:  L Verstraeten; N Van Regemorter; A Pardou; H de Verneuil; V Da Silva; F Rodesch; D Vermeylen; C Donner; J C Noël; Y Nordmann
Journal:  Eur J Clin Chem Clin Biochem       Date:  1993-03

4.  Identification of two new mutations in congenital erythropoietic porphyria.

Authors:  M Bensidhoum; C Ged; I Hombrados; F Moreau-Gaudry; R S Hift; P Meissner; E D Sturrock; H de Verneuil
Journal:  Eur J Hum Genet       Date:  1995       Impact factor: 4.246

5.  Separation of porphyrin isomers by high-performance liquid chromatography.

Authors:  C K Lim; J M Rideout; D J Wright
Journal:  Biochem J       Date:  1983-05-01       Impact factor: 3.857

6.  Human uroporphyrinogen III synthase: molecular cloning, nucleotide sequence, and expression of a full-length cDNA.

Authors:  S F Tsai; D F Bishop; R J Desnick
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

7.  Purification and properties of uroporphyrinogen III synthase from human erythrocytes.

Authors:  S F Tsai; D F Bishop; R J Desnick
Journal:  J Biol Chem       Date:  1987-01-25       Impact factor: 5.157

8.  Congenital erythropoietic porphyria: identification and expression of exonic mutations in the uroporphyrinogen III synthase gene.

Authors:  C A Warner; H W Yoo; A G Roberts; R J Desnick
Journal:  J Clin Invest       Date:  1992-02       Impact factor: 14.808

9.  Congenital erythropoietic porphyria (Günther's disease): enzymatic studies on two cases of late onset.

Authors:  J C Deybach; H de Verneuil; N Phung; Y Nordmann; A Puissant; B Boffety
Journal:  J Lab Clin Med       Date:  1981-04

10.  Congenital erythropoietic porphyria: identification and expression of 10 mutations in the uroporphyrinogen III synthase gene.

Authors:  W Xu; C A Warner; R J Desnick
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

View more
  2 in total

1.  Need for measurement of porphyrins in teardrops in patients with congenital erythropoietic porphyria.

Authors:  N Takamura; K Kurihara; S Yamashita; M Kondo
Journal:  Br J Ophthalmol       Date:  2002-10       Impact factor: 4.638

Review 2.  Congenital erythropoietic porphyria: Recent advances.

Authors:  Angelika L Erwin; Robert J Desnick
Journal:  Mol Genet Metab       Date:  2018-12-27       Impact factor: 4.797

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.